Halozyme Therapeutics reported $112.9M in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
DBV Technologies DBVT:US USD -15297000 3.22M
Acadia Pharmaceuticals ACAD:US USD -30360000 2.78M
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amarin AMRN:US USD 56.56M 93.4M
Amgen AMGN:US USD 3.04B 460M
Aptinyx Inc APTX:US USD -14557000 2.45M
Baxter International BAX:US USD 855M 68M
Cara Therapeutics CARA:US USD -23783000 19.37M
Cytokinetics CYTK:US USD -107033000 97.57M
Eli Lilly And LLY:US USD 2.31B 308.9M
Esperion Therapeutics ESPR:US USD -41518000 10.71M
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Immunogen IMGN:US USD -77005000 16.41M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Intra Cellular Therapies ITCI:US USD -55459000 32.29M
Intrexon XON:US USD -5899000 15.79M
IONIS PHARMACEUT IONS:US USD -54729000 26.4M
JAZZ PHA JAZZ:US USD 348.04M 65.49M
Mannkind MNKD:US USD -9640000 13.91M
Minerva Neurosciences NERV:US USD -5205000 1.76M
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Peregrine Pharmaceuticals PPHM:US USD -865000 5.2M
Pfizer PFE:US USD 6.94B 3.94B
United Therapeutics UTHR:US USD 327.2M 112.7M